“Design, Molecular Docking, Synthesis, Characterization and Preliminary Evaluation of Novel 1,3,4-Oxadiazole Derivatives as Cyclin-Dependent Kinase 2 Inhibitors” (2025) Al Mustansiriyah Journal of Pharmaceutical Sciences, 25(1), pp. 94–109. doi:10.32947/ajps.v25i1.1132.